Pharmaceutical Information |
Drug Name |
Sulfisoxazole |
Drug ID |
BADD_D02636 |
Description |
A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. |
Indications and Usage |
For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections. |
Marketing Status |
approved; vet_approved |
ATC Code |
J01EB05; S01AB02 |
DrugBank ID |
DB00263
|
KEGG ID |
D00450
|
MeSH ID |
D013444
|
PubChem ID |
5344
|
TTD Drug ID |
D09TBD
|
NDC Product Code |
Not Available |
UNII |
740T4C525W
|
Synonyms |
Sulfisoxazole | Sulfasoxizole | Sulfadimethyloxazole | Sulfafurazole | Sulfafurazol FNA | Sulfisoxazole Diolamine | Diolamine, Sulfisoxazole | Sulfisoxazole, Ammonium Salt | Ammonium Salt Sulfisoxazole | Sulfisoxazole, Monolithium Salt | Monolithium Salt Sulfisoxazole | V-Sul | V Sul | Sulfisoxazole, Monosodium, Monomesylate Salt | Sulfisoxazole, Triammonium Salt | Triammonium Salt Sulfisoxazole | Gantrisin | Gantrisin Pediatric | Pediatric, Gantrisin | TL-azole | TL azole | Neoxazoi | Sulfisoxazole, Monosodium Salt | Monosodium Salt Sulfisoxazole |
|
Chemical Information |
Molecular Formula |
C11H13N3O3S |
CAS Registry Number |
127-69-5 |
SMILES |
CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|